Stock Market Reviews

Read and share opinions on CLRB (Cellectar Biosciences, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mar

Latest News

• Cellectar Biosciences Inc (CLRB) Q3 2025 Earnings Call Highlights: Strategic Advances and ...
  Nov 13, 2025
• Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Thursday, November 13, 2025
  Nov 6, 2025
• Cellectar Says FDA Grants Rare Pediatric Drug Designation for Iopofosine in High-Grade Glioma
  Oct 27, 2025
• Cellectar Biosciences Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration for Iopofosine I 131 in Relapsed or Refractory Pediatric High-Grade Glioma
  Oct 27, 2025
• Cellectar Biosciences Presented Promising Preclinical Data in Poster Presentation at the American Association for Cancer Research (AACR) Special Conference on Pancreatic Cancer Research
  Oct 14, 2025
• Cellectar Biosciences, Inc. Enters Into Agreements to Raise $5.8 Million
  Oct 7, 2025
• Cellectar Biosciences Announces European Medicines Agency (EMA) Confirms Eligibility to File for Conditional Marketing Authorization (CMA) for Iopofosine I 131 as a Treatment for Refractory (post-BTKi) Waldenstrom Macroglobulinemia (WM)
  Oct 6, 2025
• Cellectar Biosciences Presented Compelling Data in Oral Session and Panel Discussions at the American Association for Cancer Research Special Conference on Discovery and Innovation in Pediatric Cancer
  Sep 30, 2025
• Cellectar and Evestia Clinical Announce Partnership to Support Auger-Emitting Radiopharmaceutical Clinical Trial in Triple-Negative Breast Cancer (TNBC)
  Sep 24, 2025
• Cellectar Biosciences and ITM Enter Supply Agreement for GMP-Grade Actinium-225
  Sep 11, 2025
• Cellectar Biosciences to Participate in Multiple Upcoming Medical Meetings and Industry Conferences in September
  Sep 5, 2025
• Cellectar Biosciences to Present Data in Poster Presentation at the American Association for Cancer Research Special Conference on Advances in Pancreatic Cancer Research
  Sep 3, 2025
• Cellectar Biosciences to Present Data in Oral Session and Panel Discussions at the American Association for Cancer Research Special Conference on Discovery and Innovation in Pediatric Cancer
  Aug 27, 2025
• Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 14, 2025
  Aug 7, 2025
• All You Need to Know About Cellectar Biosciences (CLRB) Rating Upgrade to Buy
  Jul 15, 2025
• Cellectar Biosciences Announces Closing of $6.9 Million Underwritten Public Offering, including Full Exercise of Over-Allotment Option
  Jul 2, 2025